Xiamen Hongxin Valuation Multiples

Discover Xiamen Hongxin's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Himax, LINTEC, Hesai Technology, DBG Technology Co and more.

Xiamen Hongxin Overview

About Xiamen Hongxin

Xiamen Hongxin Electronics Technology Group Inc is a China-based company engaged in designing, manufacturing, and selling Flexible Printed Circuit boards (FPC). The company-produced FPC is used as supportive services for mobile communication and various kinds of consumer electronic products. Its product portfolio covers thin double-sided FPC, wearable FPC, LCD module class, CCM module class, and hardboard, among others.


Founded

2003

HQ

China

Employees

N/A

Website

fpc98.com

Financials (FY)

Revenue: $1.1B
EBITDA: $120M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Xiamen Hongxin Financials

Xiamen Hongxin reported last fiscal year revenue of $1.1B and EBITDA of $120M.

In the same fiscal year, Xiamen Hongxin generated $134M in gross profit, $120M in EBITDA, and $22M in net income.


Xiamen Hongxin P&L

In the most recent fiscal year, Xiamen Hongxin reported revenue of $1.1B and EBITDA of $120M.

Xiamen Hongxin is profitable as of last fiscal year, with gross margin of 12%, EBITDA margin of 11%, and net margin of 2%.

See analyst estimates for Xiamen Hongxin
Last FY202320242025202620272028
Revenue$1.1B$512M$865M$1.1B
Gross Profit$134M$12M$87M$134M
Gross Margin12%2%10%12%
EBITDA$120M($25M)$78M$120M
EBITDA Margin11%(5%)9%11%
EBIT Margin7%(6%)5%7%
Net Profit$22M($64M)$8M$22M
Net Margin2%(13%)1%2%
Net Debt$165M---

Financial data powered by Morningstar, Inc.

Xiamen Hongxin Stock Performance

Xiamen Hongxin has current market cap of $2.6B, and enterprise value of $3B.


Xiamen Hongxin's stock price is $5.42.

Xiamen Hongxin has an EPS (earnings per share) of $0.04.

See more trading valuation data for Xiamen Hongxin
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$2.6B0.7%---$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Xiamen Hongxin Valuation Multiples

Xiamen Hongxin trades at 2.8x EV/Revenue multiple, and 24.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Xiamen Hongxin

Xiamen Hongxin Financial Valuation Multiples

As of July 9, 2026, Xiamen Hongxin has market cap of $2.6B and EV of $3B.

Xiamen Hongxin has a P/E ratio of 120.5x.

Last FY202320242025202620272028
EV/Revenue2.8x5.8x3.4x2.8x
EV/EBITDA24.7x(117.6x)38.0x24.7x
EV/EBIT37.5x(97.7x)67.1x37.5x
EV/Gross Profit22.1x242.4x34.1x22.1x
P/E120.5x(40.7x)n/m120.5x
EV/FCF(42.4x)n/m(21.6x)(42.4x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Xiamen Hongxin Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Xiamen Hongxin Margins & Growth Rates

In the most recent fiscal year, Xiamen Hongxin reported gross margin of 12%, EBITDA margin of 11%, and net margin of 2%.

See estimated margins and future growth rates for Xiamen Hongxin

Xiamen Hongxin Margins

Last FY20242025202720282029
Gross Margin12%10%12%
EBITDA Margin11%9%11%
EBIT Margin7%5%7%
Net Margin2%1%2%
FCF Margin(6%)(16%)(6%)

Xiamen Hongxin Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth69%24%
Gross Profit Growth611%54%
EBITDA Growth(410%)54%
EBIT Growth(246%)79%
Net Profit Growth(113%)159%
FCF Growth1537%(49%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Xiamen Hongxin Operational KPIs

Access forward-looking KPIs for Xiamen Hongxin
Last FY202320242025202620272028
S&M Expenses to Revenue0%1%0%0%
G&A Expenses to Revenue1%1%1%1%
R&D Expenses to Revenue2%3%2%2%
Opex to Revenue5%8%5%5%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Xiamen Hongxin Competitors

Xiamen Hongxin competitors include Himax, LINTEC, Hesai Technology, DBG Technology Co, AURAS Technology, Cowell e Holdings, 5N Plus, Foxconn Technology Co, MLS Co. and Nippon Electric Glass.

Most Xiamen Hongxin public comparables operate across Electronic Components.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Himax3.5x3.3x35.9x33.5x
LINTEC1.1x1.1x8.4x8.2x
Hesai Technology4.3x3.6x21.6x24.8x
DBG Technology Co1.9x-15.5x-
AURAS Technology3.7x2.9x21.9x14.9x
Cowell e Holdings0.7x0.6x8.0x7.3x
5N Plus6.8x6.1x28.7x26.3x
Foxconn Technology Co0.0x0.0x0.8x-

This data is available for Pro users. Sign up to see all Xiamen Hongxin competitors and their valuation data.

Start Free Trial

Investments by Xiamen Hongxin

Xiamen Hongxin has invested in 2 companies to date.

Latest investment by Xiamen Hongxin was on July 4th 2026. Xiamen Hongxin invested in TranscEngram in their Angel round.

See VC round multiples

Latest Investments by Xiamen Hongxin

TranscEngram
Zhongke Zhixin Integration
Description
TranscEngram is a technology company conducting research and development in artificial intelligence.
Zhongke Zhixin Integration is a semiconductor specialist focused on advanced packaging and chip integration for integrated circuits. The firm offers packaging design, system simulation, and fabrication services at www.casmeit.com. Linked to Chinese Academy of Sciences, it develops 2.5D and 3D integration technologies for high-performance computing and AI chips.
HQ Country-China
HQ City
-
Nanjing
Deal Date4 Jul 20267 Jul 2022
RoundAngelSeries B
Raisedundisclosed$22M
InvestorsSino Biopharmaceutical; ZJ Innopark (Zhangjiang Hi-Tech Park); Sichuan Jinduo; Zhangjiang Science & Technology Investment Corporation; Pudong Chuangtou; Shanghai Vulcan Capital; V Fund Management; Xiamen HongxinHuopu Touzi; Xin Ding Capital; Xiamen Hongxin
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Xiamen Hongxin investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Xiamen Hongxin

When was Xiamen Hongxin founded?Xiamen Hongxin was founded in 2003.
Where is Xiamen Hongxin headquartered?Xiamen Hongxin is headquartered in China.
Is Xiamen Hongxin publicly listed?Yes, Xiamen Hongxin is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Xiamen Hongxin?Xiamen Hongxin trades under 300657 ticker.
When did Xiamen Hongxin go public?Xiamen Hongxin went public in 2017.
Who are competitors of Xiamen Hongxin?Xiamen Hongxin main competitors include Himax, LINTEC, Hesai Technology, DBG Technology Co, AURAS Technology, Cowell e Holdings, 5N Plus, Foxconn Technology Co, MLS Co., Nippon Electric Glass.
What is the current market cap of Xiamen Hongxin?Xiamen Hongxin's current market cap is $2.6B.
What is the current revenue of Xiamen Hongxin?Xiamen Hongxin's last fiscal year revenue is $1.1B.
What is the current EV/Revenue multiple of Xiamen Hongxin?Current revenue multiple of Xiamen Hongxin is 2.8x.
Is Xiamen Hongxin profitable?No, Xiamen Hongxin is not profitable.
How many companies Xiamen Hongxin has acquired to date?Xiamen Hongxin hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Xiamen Hongxin has invested to date?As of July 2026, Xiamen Hongxin has invested in 2 companies.
In what companies Xiamen Hongxin invested in?Xiamen Hongxin invested in Zhongke Zhixin Integration and TranscEngram.

See public comps similar to Xiamen Hongxin

Lists including Xiamen Hongxin

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial